Life
Briefing: STAT+: A biotech turns to Apple Watch to study its Parkinson’s drug
Strategic angle: In this edition of STAT Health Tech: How Apple Watch is being used in a clinical trial for a Parkinson's drug, and more
editorial-staff
1 min read
Updated 23 days ago
A biotech company is leveraging the capabilities of the Apple Watch as part of its clinical trial for a drug targeting Parkinson's disease.
This initiative is expected to improve data collection regarding patient health metrics, potentially enhancing the trial's effectiveness.
The integration of wearable technology like the Apple Watch could streamline patient monitoring and provide real-time insights into treatment responses.